Search

Researchers at Mbarara University of Science and Technology conducted a study on Citropsis articulata, a traditional African medicinal plant used for erectile dysfunction. The study focused on evaluating the pharmacognostical parameters of the plant's leaves and root bark, including macroscopic and microscopic analysis, phytochemical analysis, and L-arginine content. The research aimed to provide essential information for quality control and standardization of the plant materials. The findings were published in Phytomedicine Plus and are available for further exploration. [Extracted from the article]

Researchers from the Division of Experimental Oncology in Milan, Italy, conducted a study on the prevalence and predictors of unrecognised low sexual desire in men with new onset erectile dysfunction (ED). They found that almost 30% of men seeking medical help for ED also had low sexual desire. Factors such as lower testosterone levels, lower erectile function scores, and higher rates of depressive symptoms were associated with ED and low sexual desire. The study highlights the importance of assessing sexual desire in men presenting with ED symptoms. [Extracted from the article]

A study conducted at Kaohsiung Medical University Hospital in Taiwan explored the association between the VEGF 2578C>A polymorphism, metabolic syndrome, and erectile dysfunction (ED). The research found that individuals carrying the VEGF 2578 A allele had a higher prevalence of both ED and metabolic syndrome compared to those with the CC genotype. This suggests that the VEGF 2578C>A polymorphism may be a common genetic susceptibility factor for both disorders, highlighting the need for further investigation into the underlying mechanisms. [Extracted from the article]

Researchers from Henan University of Chinese Medicine conducted a study on the relationship between homocysteine levels and erectile dysfunction (ED) risk among U.S. adult males using data from the NHANES survey. While the overall association between homocysteine and ED was not statistically significant, the study found that in individuals aged 50 and above, high homocysteine levels were significantly correlated with an increased risk of ED. The researchers suggest that controlling homocysteine levels, especially in middle-aged and older men, may help prevent and treat ED, providing a basis for future preventive strategies. [Extracted from the article]

Researchers at Armed Forces Hospitals Southern Region (AFHSR) conducted a study on the effects of kidney transplantation on erectile dysfunction (ED) in end-stage renal disease (ESRD) patients. The study found that kidney transplantation improved sexual function and restored normal sex hormone levels in male patients with ED, with better outcomes compared to hemodialysis/peritoneal dialysis. The research concluded that kidney transplantation could be beneficial for ESRD patients with ED. [Extracted from the article]

A patent application titled "Personal Use Extracorporeal Low Frequency Shock Wave Instrument And Methods Of Using Same" has been published online by the US Patent and Trademark Office. The patent application, filed by inventor Jonathan Hoffman, describes a treatment device for various ailments, including soft tissue injuries, cellulite reduction, and the treatment of male erectile dysfunction. The device works by applying low frequency shock waves to the skin, causing micro-trauma to the underlying tissue and promoting healing and increased blood flow. The assignee for this patent application is Moon Pool LLC. [Extracted from the article]

A recent meta-analysis conducted by researchers at Bogomolets National Medical University explored the association between caffeine intake and erectile dysfunction (ED). The study analyzed data from four cohort studies comprising a total of 51,665 adult men. The results indicated that there was no significant relationship between coffee consumption and the risk of ED. However, the researchers noted that the limited number of studies restricts the ability to draw definitive conclusions, and future research should focus on larger sample sizes and different dosages and forms of caffeine consumption. [Extracted from the article]

A study conducted at Danylo Halytsky Lviv National Medical University examined the impact of erectile dysfunction (ED) on the quality of life of men affected by hostilities in the Russian-Ukrainian war. The study surveyed 298 men who had been injured in combat operations and compared them to a control group of healthy men. The results showed that both age groups of men affected by hostilities experienced a mild form of ED, with lower scores compared to the control group. The study also found that the physical and mental components of health were significantly affected in the war victims, with limitations in everyday life due to unsatisfactory physical condition. The research concluded that there is a significant correlation between physical functioning and role functioning caused by emotional state. [Extracted from the article]

Researchers at Danylo Halytsky Lviv National Medical University conducted a study on men with erectile dysfunction due to combat trauma. The study aimed to assess the oxidative and nitrative stress levels in these men. The researchers found that lipid peroxidation processes were intensified and the glutathione (GSH) level was reduced in the blood serum and lymphocytes of these men. Additionally, the arginase/nitric oxide synthase (NOS) ratio was shifted towards increased NOS activity. The study suggests that further research is needed to understand the biochemical mechanisms behind erectile dysfunction caused by combat trauma. [Extracted from the article]

A recent review conducted by researchers at Federal University Sao Paulo explores the potential association between erectile dysfunction (ED) and sleep-related bruxism (SRB). While ED is a prevalent condition that affects millions of men, the link between SRB and ED is not well-established. However, some studies suggest a potential relationship. The review aims to uncover potential intersections between these two conditions and suggests that further research could lead to innovative treatment options. [Extracted from the article]

Inmode Ltd., based in Yokneam, Israel, has been issued a patent for a method of treating erectile dysfunction. The patent describes a method that uses radiofrequency (RF) energy to heat penile tissue and improve blood circulation. The method involves applying large area electrodes to the penis, with one electrode at the distal part of the penis and another electrode under another portion of the penis. The RF current flows between the electrodes, heating the entire length of the penile tissue. The method aims to provide an alternative solution to PDE5 inhibitors, which may not be effective for everyone and lack spontaneity. [Extracted from the article]

A study conducted by Hirosaki University in Aomori, Japan, explored the association between skin advanced glycation end-products (AGEs) levels, blood antioxidative vitamin and carotenoid concentrations, and severe erectile dysfunction (ED) in community-dwelling men. The study found that higher skin AGEs levels and lower blood antioxidative vitamin and carotenoid concentrations were significantly associated with severe ED. Additionally, serum zeaxanthin levels were negatively correlated with skin AGEs levels, suggesting a potential effect of zeaxanthin on ED by reducing tissue AGEs levels. This research provides new insights into the factors contributing to erectile dysfunction. [Extracted from the article]

A study conducted by researchers at Technical University Dresden in Germany has found that insufficient communication between urologists and patients, as well as a lack of interest in sex from partners, are barriers to the utilization of erectile dysfunction (ED) treatment after radical prostatectomy (RP). The study surveyed 246 patients with ED who had undergone RP, and found that 46% of them had never received ED treatment. The most important conversation partners for patients regarding ED were their partners and urologists. The study suggests that urologists should actively offer treatment options and improve communication with patients to address this issue. [Extracted from the article]

A patent application has been submitted for a non-invasive device that aims to treat erectile dysfunction (ED) and Peyronie's disease (PD). The device is an external penile device consisting of a dual sheath assembly with inflatable chambers. It can be adjusted to meet individual patient needs and is designed to induce and maintain penile erection while applying forces to treat curvature and other PD-related ailments. The device follows a treatment protocol to improve penile functionality and blood supply. [Extracted from the article]

A recent study conducted by researchers at the Federal University of Technology Akure explores the potential of Carpolobia lutea leaf extract in the management of erectile dysfunction induced by Paroxetine in rats. The study investigates the molecular effects of the extract and its interaction with proteins involved in the erection pathway. The findings suggest that the phytocompounds in Carpolobia lutea leaf extract show promise as a therapeutic agent for erectile dysfunction. This research provides valuable insights into alternative treatments for this condition. [Extracted from the article]

A study conducted by researchers at the University of Gondar in Ethiopia evaluated the knowledge, attitudes, and practices of community pharmacy technicians regarding erectile dysfunction (ED). The study included 165 respondents and utilized a standardized questionnaire to assess their knowledge, attitudes, practices, and demographic characteristics related to ED. The findings showed that pharmacy technicians had a moderate level of understanding, attitudes, and practices regarding ED. The study also found a positive association between knowledge, attitudes, and practices related to ED. [Extracted from the article]

A recent study conducted by the Institute for Health highlights the importance of monitoring methods for diagnosing erectile dysfunction (ED). While ED is commonly associated with cardiovascular diseases and age, it can also affect younger males and serve as an early indicator of compromised overall health. The study emphasizes that ED remains underdiagnosed due to factors such as reluctance to testing, concerns about privacy, and social stigma. The researchers conducted a comprehensive literature search and found that an increasing number of methods and solutions are integrating digital technologies, sensors, and data analytics for continuous monitoring and AI-assisted prediction of ED. The future of ED monitoring is expected to leverage digital technologies to enhance evaluation, monitoring, and accurate diagnosis in decentralized healthcare environments while maintaining patient privacy and driving early detection and intervention. [Extracted from the article]

A study conducted at Chiang Mai University in Thailand explored the use of 3D-printed tablets containing Mucuna extracts for the management of erectile dysfunction (ED). Mucuna contains levodopa, a compound that shows promise in treating ED. The researchers aimed to develop sustained-release tablets using semisolid extrusion 3D printing. The study identified factors affecting printability and optimized the formulation to achieve targeted levodopa release and consistency. The results showed that semisolid extrusion 3D printing guided by the design of experiments (DoE) was feasible for producing reliable 3D-printed tablets with consistent active ingredients and desired release rates. [Extracted from the article]

A recent study conducted by researchers at the University of Adelaide suggests that erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) may be linked to underlying heart problems. The researchers are calling for general practitioners to be more proactive in addressing these conditions, as they could be indicators of cardiometabolic disorders. The study found that nocturia (getting up at night to urinate) and ED are red flags for the presence of heart problems, including an increased risk of heart attacks. The researchers are developing a checklist to help healthcare practitioners identify and treat these symptoms early, potentially reducing morbidity and mortality among men. [Extracted from the article]

A report from Singapore discusses the use of high-frequency ultrasound (US) as a primary imaging modality for evaluating the penis. The US techniques can help assess anatomy, blood flow, and diagnose conditions such as vasculogenic impotence, penile trauma, and Peyronie disease. US is also valuable in follow-up procedures for vasculogenic erectile dysfunction. The report highlights the key features of various penile abnormalities, discusses differential diagnosis considerations, and briefly reviews management options. The research emphasizes the importance of image optimization, meticulous techniques, and radiologists' familiarity with the US anatomy and manifestations of penile conditions. [Extracted from the article]

A recent study conducted by researchers at the Departamento de Investigacion explored the association between erectile dysfunction (ED) and the severity of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). The study used the International Index Erectile Function (IIEF) scale, which was validated and translated into Spanish. The researchers found that while the severity of COPD was not associated with ED, the prevalence of ED in COPD patients was higher than in the general population. The study also revealed a strong association between beta-blockers and ED in COPD patients. The researchers suggest that screening for ED using the IIEF scale could be justified in COPD patients, and the association between beta-blockers and ED should be considered in clinical management. [Extracted from the article]

A recent study on erectile dysfunction in patients with multiple sclerosis has found that the disorder affects up to 80% of patients, primarily men. The main issue is the difficulty in achieving and maintaining an erection, which negatively impacts mental health and quality of life. The study suggests that diagnosing and treating these sexual dysfunctions should be a priority for neurologists, and the most commonly used drugs for treatment are phosphodiesterase type 5 inhibitors. If these drugs are not effective, other treatments may be offered, and patients may be referred to a urologist for further consultation. [Extracted from the article]

A recent study conducted by researchers at Erzincan Binali Yildirim University in Turkey explored the relationship between serum adropin levels and erectile dysfunction (ED). The study included male patients between the ages of 40 and 60 who presented with and without ED. The researchers found that serum adropin levels were significantly lower in patients with ED compared to those without ED. This suggests that adropin, which improves endothelial functions, may play a role in the development of ED. Further research is needed to fully understand the implications of these findings. [Extracted from the article]

A recent study conducted at Medical College and Hospital Kolkata in West Bengal, India, examined the prevalence of sexual dysfunction in patients with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). The study included 106 patients, with 56 undergoing medical treatment and 50 undergoing transurethral resection of the prostate (TURP). The researchers found that the severity of sexual dysfunction correlated with the severity of LUTS, and that treatment of LUTS improved erectile dysfunction (ED) but was associated with deterioration of ejaculatory dysfunction (EJD). The study concluded that TURP treatment resulted in a deterioration of ejaculatory function compared to medical treatment. [Extracted from the article]

A recent study conducted by researchers at Sichuan University in Chengdu, China, has found a potential causal link between insomnia and erectile dysfunction (ED). The study used genetic data and Mendelian randomization to analyze the association between sleep traits (insomnia, sleep duration, and chronotype) and ED. The results showed that genetically predicted insomnia was causally associated with a 1.15-fold increased risk of ED, while sleep duration and chronotype did not show a causal association. This study provides evidence that insomnia may increase the risk of ED. [Extracted from the article]

A patent application titled "Formulations And Methods For Treating Erectile Dysfunction" has been published online. The application discusses the need for effective treatments for erectile dysfunction, which affects a significant number of men. The inventors propose organic-aqueous mixtures that can solubilize phosphodiesterase inhibitors, such as vardenafil, sildenafil, and tadalafil, and enhance their permeation across mucosal membranes. The formulations include various components such as alcohols, polyethers, and weak salts, and can be administered intranasally or sublingually. The patent application provides detailed methods for preparing and using these formulations to treat erectile dysfunction. [Extracted from the article]

A recent study conducted by researchers from Aix-Marseille University in Marseille, France, aimed to assess the practices and knowledge of general practitioners (GPs) regarding erectile dysfunction (ED). The study found that ED is often overlooked by GPs, despite its potential association with underlying coronary artery disease. The survey revealed that many GPs did not follow recommended treatment guidelines and lacked knowledge about various treatment options. The researchers suggest that improving training and providing practical guidelines could help GPs better detect and manage ED, which could serve as an indicator of coronary heart disease. [Extracted from the article]

A study conducted by researchers at the Department of Urology in Ankara, Turkey, explored the use of ChatGPT, an artificial intelligence-based language model, to provide information on sexual dysfunctions such as erectile dysfunction and premature ejaculation. The study found that ChatGPT had the potential to be a reliable and useful resource for patients seeking information on these conditions. However, the researchers emphasized the need for improvements in artificial intelligence to ensure that the information provided is based on accepted sources and reduces potential risks and negative outcomes. The study was published in the Journal of Men's Health. [Extracted from the article]

A recent study conducted by King Saud University aimed to increase awareness about male reproductive health and dispel misconceptions about erectile dysfunction (ED). The study involved a live online poll during a webinar attended by healthcare professionals (HCPs) from various specialties. The poll revealed that HCPs perceive phosphodiesterase type 5 inhibitors (PDE5is) as a means to manage ED rather than a complete cure. It was also found that adherence to ED medication may decline on days without planned sexual activity, and the daily schedule of treatment may be burdensome for some patients. Overall, the study provides insights into the perspectives of HCPs regarding the usage of PDE5is for ED treatment. [Extracted from the article]

A recent study conducted by researchers at George Mason University explored the relationship between internalized gay ageism and erectile dysfunction (ED) among older gay men. The study found that internalized gay ageism was not significantly associated with ED, but age and overall health were significant factors. The researchers concluded that future research should continue to investigate other unique factors that may be associated with ED in gay men. This study provides valuable insights into the risk factors for ED in older gay men and highlights the need for further research in this area. [Extracted from the article]

New studies conducted by Lucas R. Prieto, an assistant professor at George Mason University, have found that internalized ageism and internalized gay ageism can impact the sexual health of older gay men. Internalized gay ageism negatively affects older gay men's sexual satisfaction, but not their erectile dysfunction. The research emphasizes the importance of understanding the unique experiences of aging as a gay man and providing competent care. The studies also highlight the need for tailored health interventions for older gay men to promote sexual satisfaction and overall well-being. [Extracted from the article]

A study conducted by researchers at Central South University in Changsha, China, explored the relationship between apolipoproteins (Apos) and erectile dysfunction (ED). The study used Mendelian randomization analysis to determine causal associations between lipoproteins and ED, and differentiated between organic and psychogenic causes of ED. The results showed that high-density lipoprotein (HDL), Apo A1, and Apo B/A1 were identified as risk factors for ED. The study suggests that Apo A1 and Apo A1/Apo B could be used as indicators to assess the risks associated with organic ED. [Extracted from the article]

A study conducted by researchers at the Southern University of Science and Technology Hospital in Shenzhen, China, has found that exposure to polystyrene nanoplastics (PS-NPs) can cause erectile dysfunction in rats. The study established a rat model of oral exposure to PS-NPs and found that high doses of PS-NPs triggered erectile dysfunction, while low doses did not. The toxicological effects of PS-NPs on erectile function include fibrosis in the corpus cavernosum, endothelial dysfunction, reduction in testosterone levels, elevated oxidative stress, and apoptosis. This study provides new insights into the toxicity of PS-NPs. [Extracted from the article]

A new report from researchers at the Medical University of Lodz in Poland presents fresh data on erectile dysfunction (ED). The study aimed to evaluate vascular dysfunction using the Flow-Mediated Skin Fluorescence (FMSF) technique in men with and without ED. The researchers found that men with ED had significantly lower flowmotion (FM) and vasomotion (VM) parameters, but a significantly higher Normoxia Oscillatory Index (NOI) compared to men without ED. The study suggests that the FMSF technique may be helpful in the early diagnosis of microcirculation dysfunction caused by decreased testosterone activity. [Extracted from the article]

A new report discusses research on erectile dysfunction (ED) and its relationship to physical activity. The study aimed to evaluate the association between the recommended volume of physical activity and ED in adult males. The findings showed that meeting the guideline-recommended levels of physical activity or engaging in higher volumes of physical activity reduced the odds of having ED. However, the benefits of physical activity may be diminished by smoking. This research provides support for the importance of physical activity in preventing ED. [Extracted from the article]

A recent study conducted in Usti nad Labem, Czech Republic, has found a link between erectile dysfunction (ED) and disorders of thyroid function. The study included 51 men with thyroid dysfunction, either hypofunction or hyperfunction, and found that all of them experienced some form of erectile dysfunction. Treatment for thyroid dysfunction was shown to improve erectile function, and the researchers recommend screening for thyroid dysfunction in all men with ED. The study suggests that treatment for ED with iPDE5 agents can be initiated before treatment for thyroid dysfunction. [Extracted from the article]